Michael Irungu, Suhila Sawesi, Mohamed Rashrash, Pranitha Presingu, Kyle Kane, Jon Schommer, Lawrence Brown
{"title":"Predicting pharmacy choice for managed care network design.","authors":"Michael Irungu, Suhila Sawesi, Mohamed Rashrash, Pranitha Presingu, Kyle Kane, Jon Schommer, Lawrence Brown","doi":"10.18553/jmcp.2026.32.6.679","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Pharmacy type selection is a key component of medication access and use. Prior studies have commonly used logistic regression to examine pharmacy type choice, but this approach may not fully capture complex relationships among patient characteristics.</p><p><strong>Objective: </strong>To examine patient characteristics associated with pharmacy type selection and to compare the performance of traditional logistic regression with ensemble machine learning models for predicting pharmacy type selection.</p><p><strong>Methods: </strong>We conducted a cross-sectional analysis of adults participating in the 2021 National Consumer Survey on Medication Experience (NCSME-PR; n = 1,502). The outcome was the pharmacy type selected when a prescription medication was needed, categorized as chain, independent, supermarket, mass merchandise, mail-order, or clinic-based pharmacy. Predictors included patient characteristics defined by the Andersen Behavioral Model of Health Services Use, encompassing predisposing, enabling, and need factors. We compared logistic regression with random forest and extreme gradient boosting (XGBoost) models using 5-fold cross-validation and held-out test data. Model discrimination was assessed using the area under the receiver operating characteristic curve.</p><p><strong>Results: </strong>Across pharmacy types, ensemble models demonstrated higher discrimination than logistic regression, with XGBoost achieving the highest area under the receiver operating characteristic curve values. Prior mail-order pharmacy use, number of chronic conditions, income, and US region were consistently associated with the selection of pharmacy type. Ensemble models captured nonlinear patterns in these associations that were not fully reflected in logistic regression models.</p><p><strong>Conclusions: </strong>Pharmacy type selection varies by patient characteristics and pharmacy type, and predictive performance differs by analytic approach. Comparative modeling indicates that conclusions about pharmacy choice may depend on the modeling framework used. These findings contribute to pharmacy choice research and highlight considerations for future studies using managed care administrative data.</p>","PeriodicalId":16170,"journal":{"name":"Journal of managed care & specialty pharmacy","volume":"32 6","pages":"679-690"},"PeriodicalIF":3.3000,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13193322/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of managed care & specialty pharmacy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.18553/jmcp.2026.32.6.679","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Pharmacy type selection is a key component of medication access and use. Prior studies have commonly used logistic regression to examine pharmacy type choice, but this approach may not fully capture complex relationships among patient characteristics.
Objective: To examine patient characteristics associated with pharmacy type selection and to compare the performance of traditional logistic regression with ensemble machine learning models for predicting pharmacy type selection.
Methods: We conducted a cross-sectional analysis of adults participating in the 2021 National Consumer Survey on Medication Experience (NCSME-PR; n = 1,502). The outcome was the pharmacy type selected when a prescription medication was needed, categorized as chain, independent, supermarket, mass merchandise, mail-order, or clinic-based pharmacy. Predictors included patient characteristics defined by the Andersen Behavioral Model of Health Services Use, encompassing predisposing, enabling, and need factors. We compared logistic regression with random forest and extreme gradient boosting (XGBoost) models using 5-fold cross-validation and held-out test data. Model discrimination was assessed using the area under the receiver operating characteristic curve.
Results: Across pharmacy types, ensemble models demonstrated higher discrimination than logistic regression, with XGBoost achieving the highest area under the receiver operating characteristic curve values. Prior mail-order pharmacy use, number of chronic conditions, income, and US region were consistently associated with the selection of pharmacy type. Ensemble models captured nonlinear patterns in these associations that were not fully reflected in logistic regression models.
Conclusions: Pharmacy type selection varies by patient characteristics and pharmacy type, and predictive performance differs by analytic approach. Comparative modeling indicates that conclusions about pharmacy choice may depend on the modeling framework used. These findings contribute to pharmacy choice research and highlight considerations for future studies using managed care administrative data.
期刊介绍:
JMCP welcomes research studies conducted outside of the United States that are relevant to our readership. Our audience is primarily concerned with designing policies of formulary coverage, health benefit design, and pharmaceutical programs that are based on evidence from large populations of people. Studies of pharmacist interventions conducted outside the United States that have already been extensively studied within the United States and studies of small sample sizes in non-managed care environments outside of the United States (e.g., hospitals or community pharmacies) are generally of low interest to our readership. However, studies of health outcomes and costs assessed in large populations that provide evidence for formulary coverage, health benefit design, and pharmaceutical programs are of high interest to JMCP’s readership.